Navigation Links
Use of costly breast cancer therapy strongly influenced by reimbursement policy
Date:4/28/2011

What Medicare would pay for and where a radiation oncologist practiced were two factors that strongly influenced the choice of intensity-modulated radiation therapy (IMRT) for treating breast cancer, according to an article published April 29 online in the Journal of the National Cancer Institute. The use of IMRT and the cost of radiation therapy increased sharply over the period of the study.

IMRT is a radiation delivery technique that modulates the radiation beams to conform to the shape of the tumor or tumor bed in an attempt to maximize the dose of radiation to the tumor while minimizing the dose to adjacent normal tissues. Compared to conventional, two- or three-dimensional radiation therapy, IMRT may reduce acute skin toxicity and improve cosmetic outcomes for women undergoing breast conservation therapy.

But there are simpler approaches to three-dimensional treatment that may provide the same benefits at lower cost. It is thus controversial whether such treatments justify billing Medicare for IMRT.

To look at clinical, demographic, and other factors associated with billing for IMRT in Medicare beneficiaries with breast cancer, Benjamin D. Smith, M.D., of the M. D. Anderson Cancer Center in Houston, Texas, and colleagues used Medicare data for 26,163 women with localized breast cancer who had undergone surgery and radiation therapy from 2001 through 2005.

They found that Medicare billing for IMRT increased more than 10-fold (increasing from 0.9% to 11.2% of the diagnosed patients) in that period. The average cost of radiation within the first year of diagnosis was $7,179 without IMRT and $15,230 with IMRT.

In regions of the country where local Medicare carriers covered IMRT, billing for this treatment was more than five times higher than in regions where it was not covered. Furthermore, IMRT billing was more frequent for patients treated by radiation oncologists in freestanding radiation centers (7.6% had IMRT) compared to those treated in hospital-based outpatient clinics (5.4% had IMRT).

In their discussion, the authors note that there are two ways to achieve intensity modulation of the radiation beam, one called field-in-field forward planning and one called inverse planning. The second is more expensive, requiring more physician and treatment planning time. Most Medicare carriers require inverse planning to reimburse for IMRT, although the two approaches likely have similar outcomes for treatment of the breast only, according to the authors.

They write that their data "suggest that with respect to breast radiation therapy, much of the variation in cost can be directly attributed to inconsistent treatment definitions and reimbursement rates authorized by Medicare and its intermediaries."

In an accompanying editorial, Lisa A. Kachnic, M.D., of Boston University School of Medicine, and Simon N. Powell, M.D., Ph.D., of Memorial Sloan-Kettering Cancer Center, New York, note that the evidence supporting the routine use of inverse-planned IMRT for patients requiring breast only treatment is weak. They suggest that the true value of inverse- planned IMRT will most likely be for patients with complex anatomy or those with more advanced breast cancer who require comprehensive lymph node treatment such as radiation to the internal mammary nodal chain. IMRT may also help to protect the underlying lung and heart, they say. However large randomized trials are needed to determine whether it actually has these benefits.

In the meantime, the editorialists write, this study "appears to confirm the suspicion of many, both within and outside of the healthcare industry, that medical decision making is too heavily influenced by reimbursement rather than medical necessity."


'/>"/>

Contact: Kristine Crane
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
Source:Eurekalert

Related medicine news :

1. Portable, less costly peritoneal dialysis shows no additional catheter risk factors
2. Adverse drug events costly to health care system: Vancouver Coastal Health-UBC research
3. Knee replacement surgeries take more time, are more costly in overweight individuals
4. Evidence lacking for widespread use of costly antipsychotic drugs, says Stanford researcher
5. For HIV-positive patients, delayed treatment a costly decision
6. Patients Who Swallow Foreign Objects a Costly Burden to Health Care
7. Mental health leaves most costly disability to Canadian employers
8. Does the U.S. Need to Ration Costly End-of-Life Care?
9. Costly tests may not help detect bladder cancer recurrence, M. D. Anderson study finds
10. Why do physicians order costly CTs? Ultrasound yields better diagnosis, safer, less costly
11. Study Suggests Low-Consuming Medicare Beneficiaries With Chronic Disease Are More Costly to Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... ... ... Astellas is a pharmaceutical ...
(Date:6/23/2016)... Pa. , June 23, 2016 The ... in an outpatient dialysis facility.  Treatments are usually 3 ... 6 hours per visit, including travel time, equipment preparation ... a patient, but especially grueling for patients who are ... of a skilled nursing and rehabilitation centers for some ...
(Date:6/23/2016)... YORK , June 23, 2016 ... waters, but it continues to present great opportunities to ... companies for today: Intrexon Corp. (NYSE: XON ... Arena Pharmaceuticals Inc. (NASDAQ: ARNA ), and ... more about these stocks and receive your complimentary trade ...
Breaking Medicine Technology: